Jeffrey D Marrazzo
CIK 1631262 · CHIEF EXECUTIVE OFFICER · last filed 2026-06-08
Jeffrey D Marrazzo is a CHIEF EXECUTIVE OFFICER who has filed 35 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for PRME, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$20.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
35
-$20.02M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRME | Director | — | $2.77 | — | $0 | 7 | 2026-06-08 |
| Spark Therapeutics, Inc. (ONCE) Delisted | CHIEF EXECUTIVE OFFICER | 0 | — | — | -$20.02M | 28 | 2019-12-17 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | PRME | Grant (A) | — | $0 | EDGAR |
| 2025-08-05 | PRME | Mixed | — | $0 | EDGAR |
| 2025-06-05 | PRME | Grant (A) | — | $0 | EDGAR |
| 2025-05-19 | PRME | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | PRME | Grant (A) | — | $0 | EDGAR |
| 2024-03-04 | PRME | Grant (A) | — | $0 | EDGAR |
| 2023-05-12 | PRME | Grant (A) | — | $0 | EDGAR |
| 2019-12-17 | Spark Therapeutics, Inc. (ONCE) Delisted | Mixed | −355,215 | -$40.67M | EDGAR |
| 2019-03-19 | Spark Therapeutics, Inc. (ONCE) Delisted | Exer (M) | +49,940 | $172.3K | EDGAR |
| 2019-01-23 | Spark Therapeutics, Inc. (ONCE) Delisted | Mixed | +5,921 | -$127.5K | EDGAR |